Cargando…
The immunology of COVID-19: is immune modulation an option for treatment?
In December, 2019, an outbreak of COVID-19 emerged in Wuhan, China and quickly spread globally. As of May 7, 2020, there were 3 672 238 confirmed infections and 254 045 deaths attributed to COVID-19. Evidence has shown that there are asymptomatic carriers of COVID-19 who can transmit the disease to...
Autores principales: | Zhong, Jixin, Tang, Jungen, Ye, Cong, Dong, Lingli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7239618/ https://www.ncbi.nlm.nih.gov/pubmed/32835246 http://dx.doi.org/10.1016/S2665-9913(20)30120-X |
Ejemplares similares
-
Intratracheal Poly(I:C) Exposure Accelerates the Immunological Disorder of Salivary Glands in Sjogren's-Like NOD/ShiLtJ Mice
por: Hu, Peng, et al.
Publicado: (2021) -
COVID-19: Immunology and treatment options
por: Felsenstein, Susanna, et al.
Publicado: (2020) -
Gut Microbiota Aberration in Patients of Systemic Sclerosis and Bleomycin-Induced Mice Model
por: Tang, Jungen, et al.
Publicado: (2021) -
Epidemiology and Clinical Management of Rheumatic Autoimmune Diseases in the COVID-19 Pandemic: A Review
por: Zhu, Yingzi, et al.
Publicado: (2021) -
Cardio-Immunology of Myocarditis: Focus on Immune Mechanisms and Treatment Options
por: Maisch, Bernhard
Publicado: (2019)